CzeekV インデックス

論文・技術情報追加のお知らせ

論文・技術情報追加のお知らせ

2022年5月2日~2022年5月8日の間に収集した論文情報を追加しました。(1/3)

①Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases.

フィナステリドとペイロニー病との関連性調査研究

対象DB:FAERS,EudraVigilance

②Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis.

多発性硬化症患者におけるB細胞枯渇療法関連性乾癬調査研究

対象DB:FAERS

③Anti-cancer Drugs Associated Atrial Fibrillation-An Analysis of Real-World Pharmacovigilance Data.

抗がん剤と心房細動に関するファーマコビジランス研究

対象DB:FAERS

④Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021.

乾癬関連性薬剤調査研究

対象DB:FAERS

⑤Analysis of the adverse nervous system and gastrointestinal events associated with solifenacin in older adults using the US FDA adverse event reporting system.

高齢者におけるソリフェナシン関連性神経系・胃腸有害事象解析研究

対象DB:FAERS

⑥Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.

妊娠中COVID-19ワクチン接種後の有害事象承認後調査

対象DB:VAERS

⑦Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.

ADHD刺激薬と抗精神病薬併用による薬力学的薬物相互作用としての急性運動亢進性運動障害研究

対象DB:FAERS

⑧Comprehensive analysis of ixazomib-induced adverse events using the Japanese pharmacovigilance database.

イキサゾミブ関連の有害事象解析研究

対象DB:JADER

⑨Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System.

ベンダムスチン関連皮膚障害の発症までの時間調査研究

対象DB:JADER

⑩Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database.

カルシトニン遺伝子関連ペプチド標的薬とレイノー現象との関連性調査研究

対象DB:VigiBase

⑪Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience.

スマートフォンADR報告アプリケーションの系統的評価研究

対象DB:VigiBase